Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alassane Dicko

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
The Lancet. Infectious Diseases|February 10, 2018
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trialAlassane Dicko, Michelle E Roh, Halimatou Diawara, et al.
BMC Medicine|October 6, 2022
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01<sub>E</sub> vaccination and seasonal malaria chemoprevention versus either intervention given aloneMatthew Cairns, Amadou Barry, Issaka Zongo, et al.
The Pan African Medical Journal|November 29, 2011
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiativeCharles Shey Wiysonge, George E Armah, Shabir A Madhi, et al.
BMC Public Health|May 19, 2025
Assessing the knowledge of key one health elements among African higher education students: African multi- center cross-sectional studyFatma A Amer, Nkalubo Jonathan, Hana A Nofal, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
Frontiers in Immunology|August 22, 2022
Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West AfricaJohn Woodford, Issaka Sagara, Halimatou Diawara, et al.
Elife|June 1, 2018
Predicting the likelihood and intensity of mosquito infection from sex specific <i>Plasmodium falciparum</i> gametocyte densityJohn Bradley, Will Stone, Dari F Da, et al.
Plos Pathogens|August 16, 2020
CXCR4 and MIF are required for neutrophil extracellular trap release triggered by Plasmodium-infected erythrocytesDanielle A S Rodrigues, Elisa B Prestes, Andreza M S Gama, et al.
Frontiers in Genetics|April 26, 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical TrialsNuno Sepúlveda, Lynn Grignard, Jonathan Curry, et al.
Malaria Journal|February 23, 2022
Impact of seasonal RTS,S/AS01<sub>E</sub> vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and MaliJane Grant, Issaka Sagara, Issaka Zongo, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
The Lancet. Infectious Diseases|February 10, 2018
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trialAlassane Dicko, Michelle E Roh, Halimatou Diawara, et al.
BMC Medicine|October 6, 2022
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01<sub>E</sub> vaccination and seasonal malaria chemoprevention versus either intervention given aloneMatthew Cairns, Amadou Barry, Issaka Zongo, et al.
The Pan African Medical Journal|November 29, 2011
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiativeCharles Shey Wiysonge, George E Armah, Shabir A Madhi, et al.
BMC Public Health|May 19, 2025
Assessing the knowledge of key one health elements among African higher education students: African multi- center cross-sectional studyFatma A Amer, Nkalubo Jonathan, Hana A Nofal, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
Frontiers in Immunology|August 22, 2022
Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West AfricaJohn Woodford, Issaka Sagara, Halimatou Diawara, et al.
Elife|June 1, 2018
Predicting the likelihood and intensity of mosquito infection from sex specific <i>Plasmodium falciparum</i> gametocyte densityJohn Bradley, Will Stone, Dari F Da, et al.
Plos Pathogens|August 16, 2020
CXCR4 and MIF are required for neutrophil extracellular trap release triggered by Plasmodium-infected erythrocytesDanielle A S Rodrigues, Elisa B Prestes, Andreza M S Gama, et al.
Frontiers in Genetics|April 26, 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical TrialsNuno Sepúlveda, Lynn Grignard, Jonathan Curry, et al.
Malaria Journal|February 23, 2022
Impact of seasonal RTS,S/AS01<sub>E</sub> vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and MaliJane Grant, Issaka Sagara, Issaka Zongo, et al.
Pageof 17